Unauthorized injectable peptide drugs sold by Prime Research may pose serious health risks Canada.ca fda warning bpc 157 peptide products New Details 157 FDA to weigh easing limits on unproven peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive